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INTRODUCTION
At present, physical measurements of
radiation exposure field fluxes are con-
siderably more accurate than retrospective
biologic estimates of the radiation dose
in any particular exposure incident. Row-
ever, wide individual variation in clini-
cal response to radiation exposure often
creates an apparent disagreement between
physical and biological dose estimates.
This disparity is largely caused by bio-
logic variations in radiosensitlvity and
systemic repair but is also the result of
individually different depth-dose distri-
butions owing to body size differences or
orientation geometry occurring during
otherwise equal exposures.
Medical appraisal of the range of human
biological variation in hematologic re-
sponses is needed, but has not been made
because doslmetric information about the
real depth doses to the bone marrow of in-
dividual patients is not available. The
wide spatial distribution of bone marrow
in the human skeleton makes the determina-
tion of the total averaged dose or any
local bone marrow dose difficult and at
present requires an empirical approach.
This study was performed to devise a sys-
tem for estimating individual bone marrow
doses in therapeutic radiation exposures
of leukemic patients. These measurements
are needed to make dose-response correla-
tions and to study the effect of dose pro-
traction on peripheral blood cell levels.
Such correlations are basic to medical
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management of irradiated persons since the
bone marrow is one of man's most important
radlosensitlve tissues; lethality within 60
days of acute exposures from 200 to about
i000 R usually results from hematopoletlc
failure. Some studies (refs. 1 and 2) have
shown that in selected patient populations
the human LD50/60 may approach a low of 250
fads average body-dose, but confidence in
these estimates is poor.
During extended space explorations there
may be little risk of receiving such size-
able doses acutely but there is a real
chance of accumulating doses to the marrow
that may be blologlcall# significant. True
correlation and variation of human hemato-
logic responses to total-body irradiation
(TBI) are sorely needed to help in estab-
lishing workable limits for these occupa-
tional exposures during missions in outer
space. While the studies We have made were
primarily intended for clinical uses, the
data obtained is applicable to some of the
dosimetric and shielding problems of space
medicine.
In the Oak Ridge Associated Universities
(ORAU) Medical Division program of thera-
peutic TBI, three irradiators with differ-
ent exposure rates are in use: the ORAU
low-exposure-rate total-body irradlator
(LETBI) and medlum-exposure-rate total-body
irradlator (METBI), and the University of
Tennessee-AEC Variable Dose Rate Irradia-
tion Facility (VDRIF). Each of these irra-
dlators was specifically designed to pro-
duce a uniform field of hlgh-energy-gamma
radiation for total-body exposures of large
animals and man.
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THE IRRADIATORS 
The L E T B I  f a c i l i t y  c o n s i s t s  of  a l a r g e  
o u t e r  room ( F i g .  1B) i n  w h i c h  a smal le r  e x -  
p o s u r e  room ( F i g .  1A) is c e n t r a l l y  p o s i -  ' 
t i o n e d .  E i g h t  c o b a l t - 6 0  s o u r c e s  o f  1 6  
C u r i e s  e a c h  a r e  l o c a t e d  i n  t h e  o u t e r  room 
a n d  t h e y  i r r a d i a t e  t h e  t r e a t m e n t  room f r o m  
a l l  s i d e s .  T h i s  a r r a n g e m e n t  p r 0 v i d e s . a  
r a d i a t i o n  f i e l d  u n i f o r m  t o  w i t h i n  2 1 0 2  i n  
t h e  l i v i n g  volume ( 1 6 ~ 1 6 x 8  f t )  o c c u p i e d  b y  
t h e  p a t i e n t .  T r e a t m e n t s  g i v e n  a t  a n  a v e r -  
a g e  e x p o s u r e  r a t e  o f  1 . 5  R / h r  h a v e  r a n g e d  
f r o m  3 t o  8 d a y s  d u r a t i o n  t o  p r o v i d e  t o t a l  
p r o t r a c t e d  e x p o s u r e s  up t o  250 R .  D u r i n g  
e x p o s u r e  t h e  p a t i e n t  i s  f r e e  t o  move a b o u t  
t h e  e x p o s u r e  room w h i l e  b e i n g  i r r a d i a t e d  
f o r  18  t o  2 2  h r  p e r  d a y .  T h i s  f a c i l i t y  is 
d e s c r i b e d  i n  more  d e t a i l  by A n d r e w s ,  e t  a l .  
( r e f .  3 ) .  
Figure l.-Curavay drawing of the I o w - e x p o s ~ r e - r ~ ~ e  total-body 
i r r a d i a t i o n  facility ( L E T B I )  showing: 
Centrally positioned radiation exposure/living room. 
Concrete shielded radiation c o n t a i n m e n t  room. 
T h e  remate coocrol r ~ o m  for operation of the h ' C o  
sources (only sources No. 1 . 2 , 5 . 6 . 7 ,  c and F are 
s h o w n ) ,  radiation exposure l e v e l  supervision, n u r s i n g  
and physiologic surveilance of t h e  patient. 
T h e  on-line and data p r o c e ~ s i n g  room. 
A m o d e l  o f  t h e  M E T B I  f a c i l i t y  is shown 
i n  F i g .  2 .  T h e  c o n t r o l  room is c o n n e c t e d  
by  a c u r v e d  h a l l w a y  t o  t h e  8 x 8 ~ 8  f o o t  
t r ea tmen t  room. E i g h t  c e s i u m - 1 3 1  s o u r c e s  
o f  5 0 0  C u r i e s  e a c h ,  l o c a t e d  i n  t h e  w a l l s ,  
i r r a d i a t e  t h e  c e n t r a l l y  s u s p e n d e d  t r e a t m e n t  
b e d .  The  r a d i a t i o n  f i e l d  i n  t h e  2 ~ 2 x 6  f o o t  
v o l u m e  o c c u p i e d  b y  t h e  p a t i e n t  o n  t h e  b e d  
is u n i f o r m  t o  w i t h i n  +5% o f  t h e  1 . 5  R/min  
e x p o s u r e  r a t e  i n  t h e  v o l u m e  c e n t e r .  Expo-  
s u r e  t i m e s  h e r e  r a n g e  f r o m  a f e w  m i n u t e s  t o  
a f e w  h o u r s  f o r  t o t a l  e x p o s u r e s  of 20 t o  
3 5 0  R .  A c o m p l e t e  d e s c r i p t i o n  o f  t h i s  f a -  
c i l i t y  h a s  b e e n  p u b l i s h e d  b y  B r u c e r  ( r e f .  
4 ) .  
Fipvrc I.--Cut..ray model of the .edium-axposure-r.fe coral-body 
irradiation facility ( M E I B I ) .  
The floor plan of the third irradiator
(VDRIF) used in this therapy program is
shown in Fig 3. Six cobalt-60 sources of
7700 Curies each are arranged in a rectan-
gular array with 20 ft between adjacent
sources. Exposures are done with the
patient lying on his side on a hospital
stretcher in the center of the source
array. During patient therapy five sources
are used to provide exposure over the
stretcher at a rate of 40 R/min ±5%. To
minimize the radiation hazard to hospital
attendants, who might be required to aid
the patient in case of equipment failure,
we do not use source No. i, which is near-
est the entrance to the exposure room. A
more complete description of this Irradla-
tot is given by Checka, et el. (ref. 5).
The radiation characteristics and dimen-
sions of these irradiators are summarized
in Table 1.
_zoN c_a_cr_IsTics _m _I_io_ o_ r_._ T_a:_Y._ I._mlaTOU
THE PHANTOM
VAmABLE DOSE RATE FAClLffY- FtOOR PLAN
Filurl /.--Floor pl,I of tb. U1t,,r*t_y af T,a,,***,-ato=t© Zn*rs_
C_..t*,lo/ (UT-_C) _|r_c,ltur,l le*l,rCh L,bertcor?
V,_lebl* De,* i,t* I_ra4t*_le. Yaclllty (VD_ly), |._rc*
po_i_lon, a_a £ndicl_ed b7 la, 1.6.
An Alderson Rando phantom (ref. 6) was
used as a patient analogue. This standard-
man-slzed phantom is constructed of isocya-
nets rubber, equivalent to tissue in inter-
actions with ionizing radiation. A human
skeleton and density-adjusted lungs are
contained within the otherwise solid phan-
tom. The phantom is sliced into trans-
verse sections 2.5 cm thick with holes of
5 mm diameter arranged in a 3×3-cm grid to
provide positions for thermoluminescent
dosimeters (TLD). When not in use as do-
slmeter sites, the holes are filled with
removable plugs of tlssue-equivalent
material.
Each of the 137 dosimeter sites located
within the bone-marrow locl, identified
from radiographs of the 34 transverse sec-
tions of the phantom, contained an individ-
ually calibrated TLD during periods of
irradiation similar to the exposure of the
patients.
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DOSIMETERS
Extruded lithium fluoride dosimeters 2
(l.4xl.4x7 mm) were used to make all
measurements within the phantom. These
dosimeters are well suited for this appli-
cation because of their small size, energy
independence, approximately tissue equiva-
lence, sensitivity, reusability, and ease
of handling. They have a linear response
from 10 -2 to 103 reds and a slightly
supralinear response from 103 to about
5×105 reds when radiation damage becomes a
limiting factor. In our laboratory we
found the response of freshly calibrated
dosimeters to be reproducible with a stand-
ard deviation of the order of 1-2% when
exposed under calibration conditions. Re-
peated measurements in the same position in
the phantom rarely disagree by more than
5%. We have previously reported details
for calibrating, annealing (processing for
reuse), and analyzing these dosimeters
(ref. 7).
marrow had to be calculated by first deter-
mining the average dose for a specific com-
partment and then using its percentage of
total marrow as a weighting factor. Table
2 lists the average compartment dose and
its range per 100 K of exposure from each
of the three Irradlators. Table 3 summa-
rizes the average marrow dose calculations.
TABLE 2
MARROW COMPARTMENT AVERAGE DOSE IN RADS/IO0 R
IRRADIATORS
LETBI I_TBI VDRIF
Marrow Average Average Average
Compartment Dose . Range Dose Range Dose Range
Head 82 73-89 78 71-85 68 61-74
Upper Limb 69 58-75 66 58-73 78 70-82
Girdle
Sternum 75 73-77 69 65-71 77 74-77
Ribs 63 46-76 68 62-72 75 70-84
Vertebrae 58 47-75 65 59-80 70 63-78
Sacrum 45 41-46 54 50-56 75 67-83
Lower Limb 52 44-62 59 52-71 72 63-77
Girdle
MARROW DOSE CALCULATIONS
Since the active marrow is not uniformly
distributed within the body in a simple,
well-defined volume, it was necessary to
know the spatial distribution of the marrow
to determine average marrow dose. The dis-
tribution of active marrow for normal
adults as estimated by Ellis (ref. 8) is
expressed as the percent of the total
amount located in a particular anatomical
marrow compartment, e.g., the ribs or skull.
The distribution of the dosimeters in the
marrow compartments defined by Ellis was
not proportionate to the amount of marrow
therein. For example, 19% of the 137 do-
simeters were located in ribs which con-
tained only about 8% of the total active
marrow. Therefore, average total dose to
2Dosimeter available from Harshaw Chemical
Company, Cleveland, Ohio.
TABLE 3
CALCLrLATIONS OF AVERAGE BONE-MARROW DOSE IN RA_/IO0 R
I_TB____I _TB___I VDRI___F
Pereen_
BoSe Marrow Active Bone Average Welghted_ Average Weighted* Average Weighted*
Compartment Marro- DO_e Factor Dvse Factor Dose Factor
Ue_d 13.I 82 1074 78 1022 68 891
Upper Limb 6.4 69 442 66 422 78 499
Glrdle
Sternum 2.3 75 173 69 159 77 177
Riba 7.9 63 498 68 537 75 593
Vertebrae 28.4 58 1647 65 1846 70 1988
Sacrum 13.9 45 626 5d 251 75 1043
Lower Limb 26.1 52 1357 59 1570 72 1879
Girdle
Totals 98.1% 5820 6277 7070
Average
Weigh%_ _t_ 59 64 72
* Weighted lictor = average dose x percent bone _rr_.
% Average weighted dose - _ weighted factors ÷ tot_l perce.t active bone marroW.
Total percent is 98.1 became 1.9Z of the marro_ is loclted in the heads of _he humeri
where .o measuremnts could he made.
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The compartment dose estimates in Table
2 indicate that the marrow dose distribu-
tion is different in each of these irradia-
tors. The most unexpected result is that
the LETBI 60Co gamma irradiator produces a
smaller marrow dose than the METBI 137Cs
gamma irradiator. The other irradiator
(VDRIF) produces the largest marrow dose as
would be expected on the basis of relative
penetrability of the gamma rays involved.
This apparent paradox between the LETBI and
METBI doses can be explained only on the
basis of the distance the radiation travels
try the length of the radiation path is 40%
greater in this geometry than it would be
for radiation incident at 90 °. Because of
this geometry, the LETBI average marrow
dose is the lowest of the three irradiators
studied.
The large dependence of average marrow
dose on the angle of incidence of radiation
is shown also by the study of Clifford (ref.
ii), who measured this average dose in a
rotating phantom first exposed at 90 ° and
then at several angles down to 15 ° with the
long axis of the body. Radiation energies
of 60, 100, 212, and 660 keV were used.
in the body to the deep-seated marrow sitaa His results indicate that average dose to
In the VDRIF about 80% of the radiation is
incident at 90 ° to the long axis of the
body and passes through the body's least
thickness, the anterior-posterior diameter.
This geometry provides the minimum radia-
tion-path length to all marrow sites and
therefore the largest average depth dose.
In the METBI facility the 137Cs gamma
rays are incident on the body's lon_ axis
at angles from 78-90 ° and they penetrate
the body at an angle of approximately 30 °
to its larger lateral (side to side) diam-
eter. The average length of radiation path
in this geometry, somewhat greater than in
the VDRIF, and the lower energy radiation
explain the smaller marrow dose from the
METBI exposures. However, other depth
dose studies (refs. 9 and i0) have shown a
less than 5% difference in average marrow
dose from 137Cs and 60Co gamma rays under
equal exposure geometries.
In the LETBI the exposure geometry is
complicated by the patient's freedom to
move about the large exposure room. We
have calculated the angle of incidence for
two typical positions of the patient; when
he is standing near the room center, the
average angle of incidence is about 70° ;
lying on the bed, the average angle of
incidence is only about 25 °. If we make
the assumption that the average angle of
the marrow is reduced by a factor of two
for exposures at 15 ° compared with 90 ° for
all radiation energies. In addition, he
also shows that marrow dose for 90 ° expo-
sures varies by only about ±10% over the
energy range from 60 to 660 keV and is max-
imum at about I00 keV.
Since the LETBI and METBI facilities
produce essentially omnidirectional fields,
we can compare the marrow dose estimates in
LETBI of 0.59 and METBI of 0.64 rads/R with
that predicted from Clifford's measurements
(integrated over the angular region of 0 °
to 90 ° ) of 0_2 rads/R. This agreement is
surprisingly good considering that his
estimates were based on measurements in
only eight positions in his phantom and
were primarily intended for evaluation of
potential hazards of radiations from atomic
weapons for civil defence planning.
The International Commission on Radio-
logical Protection (ICRP) (ref. 12) has de-
fined the active marrow dose as the appro-
priate radiation criterion for relating not
only short-term hematopoietic effects but
also certain late somatic biological
effects to radiation exposures. To simpli-
fy its calculations to estimate marrow dos_
the ICRP determined that the active marrow
is located at an average depth of 5 cm. To
test the validity of this simplification,
incidence is the average for these two pos_ we determined the average 5-cm dose to the
tlons, or about 45 ° , then by simple geome- phantom in each of the three irradiators.
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The circumferential 5-cm depth line was de-
fined in each of the 34 phantom sections
and divided by radii at every 30 ° . The
depth dose at the intercepts of the radii
and the 5-cm depth llne was determined by
interpolation of the depth-dose data ob-
tained from d oslmeters located in sur-
rounding gri_ positions. These were
averaged for each section and then weighted
by the mass of the section to obtain the
overall average 5-cm depth dose. The com-
parisons of these dose estimates wlth the
average marrow doses are shown in Table 4.
TABLE 4
COMPARISON OF ESTIMATED DOSE TO BONE MARRO_
WITH AVERAGE BODY DOSE AT 5-cm DEPTH
Average Actlve Average 5-cm Ratlo5-cm Depth Dose
Bone-Marrow Dose Depth Dose Marrow Dose
(In rads/lO0 R) (In fads/100 R)
LETBI 59 68 1.15
METBI 64 66 1.03
VDRIF 72 73 1.01
These data indicate that the 5-cm dose
approximates the average marrow dose quite
closely in the 137Cs gamma-ray field
(METBI) and the hlgh-flux 60Co gamma-ray
field (VDRIF) where the incident radiation
is principally at right angles to the sta-
tionary body. The agreement, while ade-
quate, is not as good for the low-exposure-
rate cobalt irradiator (LETBI) where the
incident radiation is from both above and
below a standing patient and where the
angles change as the patient slts down,
reclines, or walksabout, changing his geo-
metric relatlonship to each source.
These results also suggest that a dosim-
eter, capable of indicating simultaneously
dose rate and total accumulated dose, lo-
cated in the center of a 5-cm radius sphere
of tlssue-equlvalent material could be used
to approximate the astronaut's average
marrow dose recelved during space flight.
The dose-rate signal from this dosimeter
could also be used to indicate when maximum
shieldlhg from unidirectional exposures,
such as solar flares, is needed and to in-
dicate what vehicle orientation provides
the maximum shielding.
This study also shows clearly that
average dose to the marrow is strongly de-
pendent on the length of the radiation path
in the body. It is therefore obvious that
for equal exposure conditions, a very large
person will receive a relatively smaller
dose to the marrow than a very small person.
To determine how large this variation
due to body size wlll be, we are extending
these studies to determine body self-
shielding factors for a particular indivi-
dual rather than the idealized 70-kg man.
The exposure rate from a small radioactive
source is first measured in air and then at
the center point of phantoms of different
sizes by a hlgh-sensltlvlty whole-body
counter containing an array of eight 5×4-in.
sodium iodide crystals. The ratio of the
counts from within the phantom to the
counts in air can be used to indicate the
body's self-shlelding factor. The results
of this study are still incomplete but the
feasibility studies indicate that this ex-
perimental approach has merit. From these
studies we should obtain correction curves
relating average marrow dose to self-
shielding factor for each of our irradlator
geometries and type of source. The self-
shielding factor for each individual or
patient could then be obtained by having
him swallow a less than 1.0-microcurle
radioactive source, then counting him in
the whole-body counter when the source is
located at the center of the patient's
body.
Accurate dosimetrlc information relevant
to the biological effects unde= study are
essential for improving the reliability of
established human dose-response relations.
This is particularly true when the effects
considered are the changes in peripheral
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blood-cell levels. These studies are
limited to medical exposures because chang_
in the blood-cell levels are related to the
preirradiation levels. For these reasons,
we are seeking to obtain truly adequate do-
simetry information from which we can de-
duce dose-response relations which will aid
in space mission planning, management of
radiation accident victims, and will im-
prove the usefulness of TBI therapy of
disseminated diseases.
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